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Methods: This prospective randomized double blinded study included 60 females scheduled for
abdominal hysterectomy under general anesthesia. They were randomized into three equal groups
[20 patients each]; group C [Control]: received oral placebo and intravenous 2 cc normal saline
0.9%, group G [Gabapentin]: received 800 mg gabapentin orally and intravenous 2 cc normal saline
0.9% and group GD [Gabapentin/Dexamethasone]: received 800 mg gabapentin orally and intrave-
nous 8 mg/2 cc dexamethasone. Intraoperative fentanyl requirement, postoperative pain, sedation
and nausea and vomiting were assessed at 2, 6, 12 and 24 h postoperative. Time of the ﬁrst request
for analgesia and total postoperative meperidine dose over 24 h were calculated.
Results: Intraoperative fentanyl requirement, time of the ﬁrst analgesic request, total 24 h meper-
idine consumption and VAS score at 2 and 6 h postoperatively showed highly statistically signiﬁ-
cant difference between group (GD) [added dexamethasone to gabapentin] and gabapentin (G)
alone or control (C), meanwhile there was statistically signiﬁcant difference between (G) and (C)
groups. VAS score was statistically signiﬁcant lower among the three studied groups when assessed
at 12 h postoperatively. There were no statistically signiﬁcant differences among the three groups as
regards the postoperative sedation scale. PONV was highly statistically signiﬁcant less observed in
groups (GD) and (G) at 2 h and statistically signiﬁcant less observed at 6 h postoperatively when
compared to the control group (C).
Conclusion: Gabapentin alone reduced the intraoperative and postoperative opioid requirement as
well as postoperative pain and PONV which was signiﬁcant in comparison with the placebo effect in
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Postoperative pain affects the patient’s recovery proﬁle. Poorly
controlled pain results in increased catabolism, heart rate and
blood pressure in addition to immunosuppression [1]. Inade-
quate pain management has both physiological and psycholog-
ical unwanted consequences and prolongs the recovery and
discharge time leading to increased health care costs [2]. Post-
operative pain is not only nociceptive in nature but also consists
of inﬂammatory, neurogenic as well as visceral components [3].
Owing to the multiplicity of the mechanisms responsible for
postoperative pain, an opioid and non-opioid analgesic combi-
nation is often used as a multimodal analgesic regimen to
enhance analgesia and reduce opioid needs and side-effects [4].
Gabapentin, a structural analog of gamma aminobutyric
acid (GABA), was introduced in the United States as an anti-
convulsant, used clinically to treat epilepsy. The drug causes
amino acids release in the spinal cord dorsal horn and thus
decreasing response to neural inputs and stabilizing the ner-
vous activity. The mechanism of action of gabapentin on neu-
ropathic pain is thought to bind to the alpha 2 delta subunit of
the voltage-dependent calcium channel in the central nervous
system, reducing calcium inﬂux into the nerve terminals and
decreases the release of neurotransmitters like glutamate [5].
Gabapentin, therefore, can be used for controlling chronic
pain, as in diabetic neuropathy and other neuropathicRandomize
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pentin for postoperative pain relief [7,8]. A recent study con-
cluded that gabapentin has a role in postoperative pain
control, preoperative anxiolysis, attenuation of hemodynamic
response to intubation, prevention of postoperative nausea
and vomiting (PONV) and ﬁnally postoperative delirium [8].
Corticosteroids are used as anti-inﬂammatory as well as
anti-immunological agents. They also posses antiemetic prop-
erties and in particular dexamethasone is used commonly for
prevention of postoperative nausea and vomiting [9]. Earlier
studies showed that glucocorticoids were effective in decreas-
ing postoperative edema and pain in patients undergoing den-
tal procedures [10,11]. A number of recent studies investigated
the possible analgesic beneﬁt of a single preoperative dose of
dexamethasone [11–13]. Long-term glucocorticoid treatment
is associated with several side-effects [14]. However, it is not
clear yet if a single dose increases the risk of these side effects.
The aimof this clinical studywas to evaluate the role of combin-
ing preoperative gabapentin with dexamethasone in the manage-
ment of post-operative pain following abdominal hysterectomy.
2. Patients and methods
This is a prospective randomized controlled double blinded
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informed consent from all patients, 60 females (40–70 years
old), ASA I-II, scheduled for elective abdominal hysterecto-
mies, were allocated randomly using a closed envelope tech-
nique into three groups:
 Group (G) [gabapentin group (n= 20)]: received oral gaba-
pentin 800 mg once, one hour prior to the start of the
procedure.
 Group (GD) [gabapentin/dexamethasone group (n= 20)]:
received oral gabapentin 800 mg, one hour before surgery
then dexamethasone 8 mg intravenously just before
induction.
 Group (C) [Control group (n= 20)]: received similar look-
ing placebo capsule, with the exact same packaging as the
active capsules, one hour before surgery then 2 ml of nor-
mal saline intravenously just before induction.
Exclusion criteria included: ASA status >II, known allergy
to any of the used drugs, regular use of certain drugs (cortico-
steroids, benzodiazepines, tricyclic antidepressants, NSAIDs,
or other analgesics). The exclusion criteria also included
patients using gabapentin or pregablin preoperatively. Also
patients suffering from renal, neurological or psychiatric disor-
ders, history of peptic ulcer, diabetes mellitus, or signiﬁcant
cardiac, pulmonary or hepatic disease and body mass index
(BMI) > 35 were excluded.
All patients were instructed preoperatively for the pain
visual analog scale (VAS) for measurement of pain.
One hour before the operation, patients in groups (G) and
(GD) were given oral gabapentin 800 mg (Gabapentine
400 mg, Neurontine, Pﬁzer) with 15 ml water, while patients
in the control group (C) were given similar looking placebo
capsule. The exact same packaging was used for the placebo
capsules, as the active capsules.
All the patients were transferred to the operative theater;
routine monitors (ECG, pulse oximetry and noninvasive BP)
were applied and 18 gauge intravenous cannula was inserted
followed by infusion of 500 ml Ringer’s Acetate.
Just before induction of anesthesia, all the patients in the
gabapentin/dexamethasone group (GD) were given 8 mg dexa-
methasone in 2 ml intravenously and all the patients in the
gabapentin group (G) and the control group (C) were given
the same volume of normal saline.
After 3–5 min of preoxygenation, induction of general anes-
thesia was carried out using fentanyl 1–2 lg/kg, and propofol
2 mg/kg. Endotracheal intubation was facilitated by atracuri-
um 0.5 mg/kg. Anesthesia was maintained with sevoﬂurane 1
MAC, 100% oxygen and muscle relaxation was maintained
with atracurium top-up doses of 0.1 mg/kg when needed.Table 1 Patients demographic data, operative time and intraoperat
Parameter Group (C) (n= 19)
Age (Year) 55 ± 10
BMI (Kg/m2) 27 ± 3.5
Operative time (min.) 114 ± 9
Intraoperative fentanyl requirement (lg) 187 ± 42
Group (C) = control, Group (G) = Gabapentin and Group (GD) = Ga
* Statistically signiﬁcant compared to the Control group (C), (p < 0.05).
 Statistically highly signiﬁcant compared to group (C) and (G), (p < 0.0Lungs were mechanically ventilated to keep end-tidal CO2
between 30 and 35 mmHg. Fentanyl increments of 50 lg were
given to maintain blood pressure and heart rate within 20% of
the preoperative values.
At the end of the procedure Sevoﬂurane was discontinued
and the neuromuscular blockade was reversed using neostig-
mine 0.05 mg/kg and atropine 0.02 mg/kg. After extubation,
patients were transferred to the post-anesthesia care unit
(PACU), and Paracetamol One gram was infused intrave-
nously upon arrival. The patients were monitored for at least
two hours, till full recovery and assessment of pain and
sedation.
Postoperative analgesia was prescribed as; Paracetamol
1 gm IV infusion, 6 hourly. Meperidine was prescribed as
25–50 mg IV if the pain score was > 3 at the assessment time
or as SOS between the assessments visits, provided that 4 h
passed since the last dose.
The following parameters were evaluated:
 Demographic data of the patients (Age and BMI).
 Operative duration.
 Intraoperative fentanyl requirement.
 Time for the ﬁrst request for analgesia postoperatively (as
primary outcome) was recorded and the total dose of
meperidine over the 24 h postoperative was calculated.
 Postoperative Pain Severity was assessed using visual ana-
log score (VAS) where (0 = no pain and 10 = worst pain),
at 2, 6, 12 and 24 h postoperative.
 Postoperative Sedation Level was assessed at the same
intervals as VAS using a 4-point scale (1 = fully awake;
2 = somnolent, responds to verbal stimuli; 3 = somnolent,
responds to tactile stimuli; and 4 = somnolent, responds to
painful stimuli).
 Postoperative Nausea and Vomiting (PONV) was measured
at the same intervals using a categorical scoring system
(none = 0, mild = 1, moderate = 2, and severe = 3).
Ondansetron 4 mg IV was prescribed for patients who
complained of nausea or vomiting.
3. Sample size calculation
Power analysis was performed using one way Analysis of Var-
iance (ANOVA) on time to ﬁrst analgesic supplementation
because it was the main outcome variable in the present study.
A previous study (8) showed that the mean of the time to ﬁrst
analgesic supplementation was about 14.5 h with a standard
deviation of 3.5 h in the gabapentin with dexamethasone
group, the mean of the time to ﬁrst analgesic supplementationive fentanyl requirement [data represented as mean ± SD].
Group (G) (n= 19) Group (GD) (n= 19) P value
58 ± 9 54 ± 9 0.647
26 ± 3.7 27 ± 3.7 0.679
115 ± 8 118 ± 8 0.908
167 ± 24* 130 ± 25 0.000
bapentin/Dexamethasone.
01).
Table 2 Time for ﬁrst analgesic request and total meperidine dose during the ﬁrst 24 h postoperatively [data represented as
Mean ± SD].
Parameter Group (C) (n= 19) Group (G) (n= 19) Group (GD) (n= 19) P value
Time for 1st analgesic request (min) 44 ± 6 49 ± 6* 72 ± 5 0.000
Postop. meperidine consumption (mg) 130 ± 29 115 ± 23* 75 ± 25 0.000
Group (C) = control, Group (G) = Gabapentin and Group (GD) = Gabapentin/Dexamethasone.
* Statistically signiﬁcant compared to the Control group (C), (p < 0.05).
 Statistically highly signiﬁcant compared to group (C) and (G), (p < 0.001).
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tin group and the mean of the time to ﬁrst analgesic supple-
mentation was 5.85 h with a standard deviation of 1.87 h in
the placebo group. Taking power of 0. 95 and alpha error
0.05, a minimum sample size of 18 patients is calculated for
each group. A total number of 20 patients in each group will
be included to compensate for the possible dropouts.4. Statistical analysis
Data management and analysis were performed using IBM
SPSS Advanced Statistics version 20.0 (SPSS Inc., Chicago,
IL). The data were statistically presented in terms of Median
(range) & Mean ± standard deviation. Comparisons among
numerical variables of three groups were done by one way
ANOVA for parametric data or repeated measure ANOVA
for non-parametric data. All P-values were considered signiﬁ-
cant when P-value is less than 0.05 and highly signiﬁcant when
P-value is less than 0.001.
5. Results
The results of the present study showed no statistically signif-
icant difference among the three studied groups as regards the
demographic data of the patients and the operative duration.
Meanwhile, the total intraoperative fentanyl requirement was
statistically signiﬁcant lower (p< 0.05) in gabapentin (G)
group compared to the control group (C), and it was highly
statistically signiﬁcant lower (p< 0.001) in gabapentin/dexa-
methasone (GD) group compared to both group (C) and
group (G), Table 1.
The time for the ﬁrst request for postoperative analgesics
was highly statistically signiﬁcant (p< 0.001) prolonged in
group (GD) when compared to either group (G) or group (C),
with its values were (72 ± 5), (49 ± 6) and (44 ± 6) min,
respectively. However this time showed statistically signiﬁcantTable 3 Post-operative VAS [data represented as median (range)].
Parameter Group (C) (n= 19) Group
2 h post-operative 5 (3–6) 4 (3–5)*
6 h post-operative 4.5 (3–5) 4 (3–5)*
12 h post-operative 4 (3–4) 3 (3–4)*
24 h post-operative 2.5 (2–3) 2 (2–3)
Group (C) = control, Group (G) = Gabapentin and Group (GD) = Ga
* Statistically signiﬁcant compared to the Control group (C), (p < 0.05).
 Statistically highly signiﬁcant compared to group (C) and group (G), (
 Statistically signiﬁcant compared to the Control group (C), (p < 0.05).difference between the gabapentin (G) group and control group
(C) (p< 0.05), we found that this difference was not clinically
that signiﬁcant, Table 2.
The total 24 h postoperative meperidine dose showed high
statistically signiﬁcant (p< 0.001) lower value in gabapentin/
dexamethasone (GD) group compared to either gabapentin
(G) or the control (C) groups, being (75 ± 25), (115 ± 23)
and (130 ± 29) mg, respectively. The difference between group
(G) and the control group (C) was statistically signiﬁcant
(p< 0.05), being lower in the former, Table 2.
The visual analog score (VAS) when compared among the
three groups 2 h postoperatively showed high statistically sig-
niﬁcant (p< 0.001) lower value in gabapentin/dexamethasone
(GD) group compared to the gabapentin (G) and the control
(C) groups, being [3 (3–4),4 (3–5)] and [5 (3–6)], respectively.
Also, the 6 h postoperative values showed the same statistically
signiﬁcant pattern of differences among the three groups,
Table 3.
Visual analog score values of the 12 h postoperative read-
ings, showed that, the values of group (GD) were statistically
signiﬁcant (p< 0.05) lower compared to group (G) and to
the control group (C), being [3 (3–4),3 (3–4)] and [4 (3–4)],
respectively. Meanwhile, there were no statistically signiﬁcant
differences among the three groups at 24 h postoperatively,
Table 3.
The results of the present study showed no statistically sig-
niﬁcant differences among the three groups as regards the
postoperative sedation scores when assessed at 2, 6, 12, and
24 h postoperatively, Table 4.
The Postoperative Nausea and Vomiting (PONV) at 2 h
postoperatively, showed highly statistically signiﬁcant
(p< 0.001) lower values in groups (GD) and (G) when com-
pared to the control groups (4/19), (3/19) and (13/19), respec-
tively. Meanwhile, there was no statistically signiﬁcant
difference between group (GD) and (G), Table 5.
At 6 h postoperatively, PONV score showed statistically
signiﬁcant (p< 0.05) lower values in groups (GD) and (G)(G) (n= 19) Group (GD) (n= 19) P value
3 (3–4) 0.000
3 (3–4) 0.000
3 (3–4) 0.024
2 (2–3) 0.117
bapentin/Dexamethasone.
p < 0.001).
Table 4 Post-operative sedation score [data represented as median (range)].
Parameter Group (C) (n= 19) Group (G) (n= 19) Group (GD) (n= 19) P value
2 h post-operative 3 (2–3) 2 (2–3) 3 (2–3) 0.154
6 h post-operative 3 (1–3) 3 (1–3) 3 (3–3) 0.908
12Hours post-operative 3 (2–3) 3 (2–3) 2.5 (1–3) 0.23
24Hours Post-operative 1 (1–2) 1.5 (1–2) 1 (1–2) 0.268
Group (C) = control, Group (G) = Gabapentin and Group (GD) = Gabapentin/Dexamethasone.
There were No Statistically signiﬁcant differences among the three groups.
Table 5 Post-operative Nausea and Vomiting (PONV) [data represented as number of patients].
Parameter Group (C) (n= 19) Group (G) (n= 19) Group (GD) (n= 19) P value
2 h post-operative 13/20 3/20 4/20 0.000
6 h post-operative 9/20 3/20* 4/20* 0.017
12 h postoperative 3/20 3/20 3/20 0.995
24 h postoperative 1/20 0/20 1/20 0.601
Group (C) = control, Group (G) = Gabapentin and Group (GD) = Gabapentin/Dexamethasone.
* Statistically signiﬁcant compared to the Control group (C), (p < 0.05).
 Statistically highly signiﬁcant compared to group (C), (p < 0.001).
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respectively. Meanwhile, there was no statistically signiﬁcant
difference between group (GD) and (G). There were no statis-
tically signiﬁcant differences among the three groups as
regards PONV when assessed at 12, and 24 h postoperatively,
Table 5.
6. Discussion
The present, prospective randomized double-blinded study
was performed to compare the effect of preemptive administra-
tion of oral gabapentin alone or in combination with intrave-
nous dexamethasone on intraoperative fentanyl requirements,
postoperative pain relief and sedation, total 24 h postoperative
meperidine requirements as well as incidence of postoperative
nausea and vomiting after elective abdominal hysterectomies.
Post-operative pain consists of nociceptive, inﬂammatory, neu-
rogenic as well as visceral components. Multimodal analgesic
techniques combining different drugs and thus obtaining syn-
ergistic and additive effects are recommended [3]. In the pres-
ent study it was assumed that both gabapentin and
dexamethasone have a different mechanism of action in acute
pain management and therefore if they are used together they
will have a synergistic effect with a possible reduction of the
side effects.
The results of the present study showed a highly statistically
signiﬁcant difference between group GD and both G and C
groups as regards the time for the ﬁrst analgesic request as well
as total meperidine consumption. Also a highly statistically sig-
niﬁcant difference in the VAS score was found between group
(GD) and both (G) and (C) groups at 2 and 6 h postopera-
tively and a statistically signiﬁcant difference was found
between both (G) and (C) groups at the same time intervals
as well. These results proved that preoperative administration
of gabapentin is valuable while combining gabapentin with
dexamethasone is of a greater value.The results of the present study best correlate with the
results of the study done by Dirks et al., who reported a
decrease in pain scores after one dose of gabapentin in mastec-
tomy patients [15]. Our results also resembled those of Sen
et al., which showed that gabapentin and ketamine have simi-
lar effect on early pain control and decreased opioid require-
ment following hysterectomies [16].
Similarly, Durmus et al., studied the effects of 1200 mg
gabapentin and a combination of gabapentin with acetamino-
phen in comparison with placebo in hysterectomy patients.
Pain scores and morphine requirement decreased in either
groups compared with placebo [7].
The results of the present study correlate with those of the
study done by Sabry Mohammad, who studied the effect of oral
gabapentin 10 mg/kg given 2 h before adenotonsillectomy, in
children, alone and combined with dexamethasone 0.15 mg/kg
after anesthesia induction. Gabapentin/dexamethasone combi-
nation signiﬁcantly reduced the post-operative pain scores and
opioid requirements without signiﬁcant side-effects [8].
In contrast to the present study, the study done by Dier-
king et al., showed no difference in postoperative pain after
hysterectomy in patients treated with either 3000 mg gaba-
pentin or placebo [17]. This contradiction may be attributed
to their administration of PCA (patient controlled analgesia)
of morphine of 2.5 mg with a lock-out time of 10 min for
24 h postoperatively, for all patients, whatever the reported
pain score.
Again, the results of the present study were in disagreement
with the results of the study done by Bartholdy et al., who
examined the effect of gabapentin on morphine consumption
and pain after laparoscopic sterilization, where no signiﬁcant
difference was detected between gabapentin and placebo
regarding pain or morphine consumption [18]. This might be
explained by the relatively less painful laparoscopic tubal liga-
tion compared to the open hysterectomy as well as the shorter
time of oral intake of gabapentin (only 30 min) before surgery,
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drug to imply a preemptive effect.
Still, results of the present study were in agreement with the
results of Thangaswamy et al. which showed that, patients trea-
ted preoperatively with 8 mg dexamethasone had a signiﬁ-
cantly longer time to ﬁrst analgesic dose and consumed
signiﬁcantly less opioid than both those pretreated with 4 mg
dexamethasone and the control, during the ﬁrst 24 h postoper-
atively following total laparoscopic hysterectomy [19].
Also the results of the present study were in accordance
with those of Kaan et al. who studied the effect of preoperative
dexamethasone on early postoperative pain after tonsillectomy
and concluded that pre-operative dexamethasone use signiﬁ-
cantly reduced early post-operative pain [20].
The results of the present study showed no statistically
signiﬁcant difference among the three groups as regards
the postoperative sedation score. These ﬁndings may be
assumed to known sedative effect of gabapentin in groups
(GD) and (G) and to the early time for the ﬁrst request
for postoperative meperidine (44 ± 6 min), and the higher
total meperidine requirement (130 ± 29 mg) in the control
group, which affected the patients somnolence making the
sedation score comparable with the gabapentin groups (G)
and (GD).
These ﬁndings were in agreement with systematic review by
Ole Mathiesen et al. who concluded that the well known seda-
tive effect of gabapentin may be masked by the opioids used
and also because patients were monitored in the early recovery
phase after general anesthesia [21].
In contrast to our study,Mikkelsen et al., reported different
complications associated with gabapentin such as sedation,
dizziness and gait disturbance, which occurred more signiﬁ-
cantly than placebo. However this study used 1800 mg/day
of gabapentin for 5 days [22].
The results of the present study showed highly statistically
signiﬁcant (P< 0.001) lower PONV values in the (G) and
(GD) groups compared to the control group (C) at 2 h postop-
eratively. Also, these values were statistically signiﬁcant
(P< 0.05) lower in the (G) and (GD) groups compared to
the control group (C) at 6 h postoperatively. These ﬁndings
may be assumed to the proved antiemetic effect of gabapentin
and dexamethasone as well as the earlier and higher total
meperidine requirement in the control group.
The ﬁndings of the present study were in agreement with
the study done by Koc¸ et al., who concluded that combination
of gabapentin and dexamethasone together an hour before
varicocele surgery prevents postoperative nausea and vomiting
better than if each drug is given alone [23].
Also, the present study was in agreement with that done by
Czarnetzki et al., regarding the risk of nausea and vomiting
and postoperative bleeding after tonsillectomy in children,
showing that, dexamethasone has a signiﬁcant and dose-
dependent antiemetic effect [24].
The results of the present study were not matching the
results of the review by Ole Mathiesen, et al., who noticed that,
in spinal surgery patients, despite of the opioid sparing effect
in gabapentin treated groups, nausea and vomiting were
non-signiﬁcant from the control groups [21].
The present study has some limitations such as; using a sin-
gle concentration of gabapentin or dexamethasone, time of
administration of studied drugs and using a particular pain
scoring system, so, changing the drugs concentration, timing,the pain scoring, or studying a larger sample size might have
an effect on the study results.
7. Conclusion
Gabapentin alone reduced the intraoperative and postopera-
tive opioid requirement as well as postoperative pain and
PONV which was signiﬁcant in comparison with the placebo
effect in the control. Obviously these effects were more prom-
inent and highly signiﬁcant when dexamethasone was added to
gabapentin.
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